595 related articles for article (PubMed ID: 17881373)
1. Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition.
Královicová J; Vorechovsky I
Nucleic Acids Res; 2007; 35(19):6399-413. PubMed ID: 17881373
[TBL] [Abstract][Full Text] [Related]
2. Computational analysis of splicing errors and mutations in human transcripts.
Kurmangaliyev YZ; Gelfand MS
BMC Genomics; 2008 Jan; 9():13. PubMed ID: 18194514
[TBL] [Abstract][Full Text] [Related]
3. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
4. Biased exon/intron distribution of cryptic and de novo 3' splice sites.
Královicová J; Christensen MB; Vorechovský I
Nucleic Acids Res; 2005; 33(15):4882-98. PubMed ID: 16141195
[TBL] [Abstract][Full Text] [Related]
5. Identification of splicing silencers and enhancers in sense Alus: a role for pseudoacceptors in splice site repression.
Lei H; Vorechovsky I
Mol Cell Biol; 2005 Aug; 25(16):6912-20. PubMed ID: 16055705
[TBL] [Abstract][Full Text] [Related]
6. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
7. A systematic analysis of intronic sequences downstream of 5' splice sites reveals a widespread role for U-rich motifs and TIA1/TIAL1 proteins in alternative splicing regulation.
Aznarez I; Barash Y; Shai O; He D; Zielenski J; Tsui LC; Parkinson J; Frey BJ; Rommens JM; Blencowe BJ
Genome Res; 2008 Aug; 18(8):1247-58. PubMed ID: 18456862
[TBL] [Abstract][Full Text] [Related]
8. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W
Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959
[TBL] [Abstract][Full Text] [Related]
9. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
10. Conserved RNA cis-elements regulate alternative splicing of Lepidopteran doublesex.
Wang XY; Zheng ZZ; Song HS; Xu YZ
Insect Biochem Mol Biol; 2014 Jan; 44():1-11. PubMed ID: 24239545
[TBL] [Abstract][Full Text] [Related]
11. Computational searches for splicing signals.
Zhang XH; Leslie CS; Chasin LA
Methods; 2005 Dec; 37(4):292-305. PubMed ID: 16314258
[TBL] [Abstract][Full Text] [Related]
12. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
[TBL] [Abstract][Full Text] [Related]
13. Why Selection Might Be Stronger When Populations Are Small: Intron Size and Density Predict within and between-Species Usage of Exonic Splice Associated cis-Motifs.
Wu X; Hurst LD
Mol Biol Evol; 2015 Jul; 32(7):1847-61. PubMed ID: 25771198
[TBL] [Abstract][Full Text] [Related]
14. A novel single-base substitution (380C>T) that activates a 5-base downstream cryptic splice-acceptor site within exon 5 in almost all transcripts in the human mitochondrial acetoacetyl-CoA thiolase gene.
Nakamura K; Fukao T; Perez-Cerda C; Luque C; Song XQ; Naiki Y; Kohno Y; Ugarte M; Kondo N
Mol Genet Metab; 2001 Feb; 72(2):115-21. PubMed ID: 11161837
[TBL] [Abstract][Full Text] [Related]
15. Subtle discrepancies of SF2/ASF ESE sequence motif among human tissues: A computational approach.
Siala O; Rebai A; Baklouti F; Fakhfakh F
Comput Biol Chem; 2010 Jun; 34(3):203-9. PubMed ID: 20637698
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic consequences of branch point substitutions.
Královicová J; Lei H; Vorechovský I
Hum Mutat; 2006 Aug; 27(8):803-13. PubMed ID: 16835862
[TBL] [Abstract][Full Text] [Related]
17. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
Hennig EE; Conney AH; Wei SJ
Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
[TBL] [Abstract][Full Text] [Related]
18. The effect of disease-associated HRPT2 mutations on splicing.
Hahn MA; McDonnell J; Marsh DJ
J Endocrinol; 2009 Jun; 201(3):387-96. PubMed ID: 19332451
[TBL] [Abstract][Full Text] [Related]
19. Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: molecular pathology of mutations in PAH exon 11.
Heintz C; Dobrowolski SF; Andersen HS; Demirkol M; Blau N; Andresen BS
Mol Genet Metab; 2012 Aug; 106(4):403-11. PubMed ID: 22698810
[TBL] [Abstract][Full Text] [Related]
20. Aberrant 3' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.
Vorechovský I
Nucleic Acids Res; 2006; 34(16):4630-41. PubMed ID: 16963498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
